Pazopanib ameliorates acute lung injuries via inhibition of MAP3K2 and MAP3K3
- 28 April 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (591)
Abstract
MAP3K inhibition attenuates acute lung injuries in mice and reduced edema in lung transplantation recipients.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R35HL135805)
- National Heart, Lung, and Blood Institute (HL145152)
- National Institute of General Medical Sciences (R01RGM131642)
This publication has 75 references indexed in Scilit:
- c-Kit Is Essential for Alveolar Maintenance and Protection from Emphysema-like Disease in MiceAmerican Journal of Respiratory and Critical Care Medicine, 2011
- The Acute Respiratory Distress Syndrome: Pathogenesis and TreatmentAnnual Review of Pathology: Mechanisms of Disease, 2011
- The Kinases MEKK2 and MEKK3 Regulate Transforming Growth Factor-β-Mediated Helper T Cell DifferentiationImmunity, 2011
- Acute Lung Injury: Epidemiology, Pathogenesis, and TreatmentJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- Comparative pharmacology of chemically distinct NADPH oxidase inhibitorsBritish Journal of Pharmacology, 2010
- Emerging Evidence for the Importance of Phosphorylation in the Regulation of NADPH OxidasesAntioxidants & Redox Signaling, 2009
- Genetic deficiency of NADPH oxidase does not diminish, but rather enhances, LPS-induced acute inflammatory responses in vivoFree Radical Biology and Medicine, 2009
- Akt activates NOS3 and separately restores barrier integrity in H2O2-stressed human cardiac microvascular endotheliumAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- The Immunological Genome Project: networks of gene expression in immune cellsNature Immunology, 2008
- MEKK3 is essential for lipopolysaccharide‐induced interleukin‐6 and granulocyte–macrophage colony‐stimulating factor production in macrophagesImmunology, 2006